PlainRecalls
FDA Drug Moderate Class II Terminated

Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.

Reported: October 7, 2020 Initiated: September 4, 2020 #D-0003-2021

Product Description

Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.

Reason for Recall

Failed Stability Specifications: Below specification result for buprenorphine release rate.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
32,543 cartons
Distribution
Nationwide in the U.S. and PR
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.. Recalled by Teva Pharmaceuticals USA. Units affected: 32,543 cartons.
Why was this product recalled?
Failed Stability Specifications: Below specification result for buprenorphine release rate.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 7, 2020. Severity: Moderate. Recall number: D-0003-2021.